sb 203580 has been researched along with Disease, Pulmonary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breysse, PN; Chiang, ET; Chillrud, SN; Garcia, JG; Geyh, AS; Lang, GD; Moreno-Vinasco, L; Natarajan, V; Pendyala, S; Samet, JM; Wang, T | 1 |
| Alam, J; Bedard, EL; Choi, AM; Lee, PJ; Potter, R; Zhang, X; Zhong, R | 1 |
| Crisostomo, PR; Meldrum, DR; Morrell, ED; Tsai, BM; Wang, M | 1 |
3 other study(ies) available for sb 203580 and Disease, Pulmonary
| Article | Year |
|---|---|
Particulate matter disrupts human lung endothelial barrier integrity via ROS- and p38 MAPK-dependent pathways.
Topics: Acetylcysteine; Air Pollutants; Antioxidants; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Lung; Lung Diseases; Molecular Chaperones; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Particulate Matter; Phosphorylation; Pyridines; Reactive Oxygen Species | 2010 |
Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury.
Topics: Animals; Aorta; Cells, Cultured; Enhancer Elements, Genetic; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Imidazoles; Lung Diseases; MAP Kinase Signaling System; Membrane Proteins; Mice; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Mutagenesis; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Pulmonary Artery; Pyridines; Rats; Reperfusion Injury; RNA, Messenger; Transcription, Genetic | 2002 |
p38 mitogen-activated protein kinase mediates the sustained phase of hypoxic pulmonary vasoconstriction and plays a role in phase I vasodilation.
Topics: Animals; Anisomycin; Enzyme Activation; Enzyme Inhibitors; Hypoxia; Imidazoles; Isometric Contraction; Lung Diseases; Male; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Pulmonary Artery; Pyridines; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasodilation | 2006 |